2421 – 2430 of 3463
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Towards an understanding of fatigue in Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Population-based study of antiepileptic drug exposure in utero-Influence on head circumference in newborns
(
- Contribution to journal › Article
-
Mark
Longitudinal study of CSF biomarkers in patients with Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Impact of cumulative dose and time on magnetic resonance imaging and clinical outcomes during long-term treatment with subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis: exploratory analyses
2009) 25th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis In Multiple Sclerosis Journal 15(9). p.126-127(
- Contribution to journal › Published meeting abstract
-
Mark
Concentrations of Metals, beta-Amyloid and Tau-Markers in Cerebrospinal Fluid in Patients with Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Neurogenesis In The Dentate Gyrus: Adaptive Alterations Of Synaptic Drive On Cells Born In Epileptic And Inflammatory Environment
(
- Contribution to journal › Published meeting abstract
-
Mark
E3 domain of laminin alpha 1 chain that binds to dystroglycan is not essential for survival and muscle regeneration in laminin alpha 1 chain mediated correction of laminin alpha 2 chain deficiency
2009) 14th International Congress of the World-Muscle-Society In Neuromuscular Disorders 19(8-9). p.598-599(
- Contribution to journal › Published meeting abstract
-
Mark
Recommendations on the diagnosis and management of Niemann-Pick disease type C
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
EPILEPSY, HEALTH CARE COST AND LOSS OF PRODUCTIVITY IN SWEDEN: A REGISTER-BASED APPROACH
(
- Contribution to journal › Published meeting abstract
-
Mark
Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT(1A) and 5-HT(1B) receptor agonists in the rat Parkinson model.
(
- Contribution to journal › Article